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ABSTRACT 
N-Acetylglutamate synthetase catalyses the reaction of glutamate and acetyl-CoA to 
produce N-acetylglutamate (NAG), which is an essential activator of carbamoyl phosphate 
synthase I (CPS I). CPS I is the flux-controlling enzyme of the urea cycle. Hepatic glutaminase is 
believed to be associated with the urea cycle but the nature of this association is not fully 
understood. Our hypothesis is that hepatic glutaminase provides glutamate for N-acetylglutamate 
synthesis. Therefore, factors which increase glutaminase activity should activate CPS I by 
increasing NAG levels. 
We investigated the effects of the known activators of glutaminase, glucagon and NH4Cl, 
in perfused rat livers. Mitochondria were subsequently prepared from these livers and NAG 
levels and citrulline synthesis assessed. Both glucagon (10-7 M) and NH4Cl (1 mM) increased 
·· mitochondrial NAG -levels and the rate of citrulline synthesis. This ·was in agreement with 
previous results. 
We proceeded to investigate whether a link between glutaminase activity and NAG levels 
existed.We employed 6-diazo-5-oxo-norleucine, DON, a compound we found to be a suitable 
inhibitor of glutaminase activity. Glucagon significantly increased NAG and citrulline synthesis 
in mitochondria prepared from hepatocyte incubations. However, pre-incubation ofhepatocytes 
with DON significantly decreased the stimulatory effect of glucagon on NAG levels and 
subsequent citrulline synthesis. Hepatocyte incubations with 1 mM ammonia also yielded a 
significant increase in mitochondrial NAG levels. Once again, pre-incubation ofhepatocytes 
with DON significantly inhibited the effect mediated by ammonia on mitochondrial NAG 
content. These results suggest a link between glutaminase activation and mitochondrial levels of 
v 
NAG. 
The increase in mitochondrial NAG due to ammonia stimulation, however, did not 
correlate with an increase in the rate of citrulline synthesis. Therefore, there may exist some 
means by which mitochondria down regulate the activation of citrulline synthesis despite 
elevated levels ofNAG. The mechanism by which the kinetic relationship between NAG levels 
and citrulline synthesis is disrupted remains unknown. Our results have led us to suggest that 
glutaminase may indirectly affect urea production through its effects on NAG levels. 
Vl 
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Increased catabolism of proteins (endogenous or dietary) results in an increased 
production of amino acids that can be catabolized through a number of metabolic processes. 
These pathways lead to the production of ammonia, which at modest circulating concentrations is 
a potent neurotoxin (Meijer et aL 1990). In mammals, the major metabolic pathway for removal 
of ammonia is the urea cycle. This cycle, which is located in the periportal region of the liver 
acinus, assimilates two nitrogen atoms and one bicarbonate molecule into a non-toxic product, 
urea. Acute control of this pathway allows for ammonia levels to be tightly regulated to avoid 
toxicity and for safe excretion of nitrogen from the body. 
Urea Cycle 
The urea cycle is located in the periportal region of the hepatic acinus where it acts as a 
low affinity but high capacity system for the removal of ammonia (Haussinger et aL 1992) The 
cycle is made up of :five major enzymes; carbamoyl-phosphate synthase I (CPS I), ornithine 
transcarbamoylase (OTC), argininosuccinate synthetase (ASS), argininosuccinate lyase (ASL) 
and arginase (Watford, 1991). The enzymes of this cycle are not localized in the same 
compartment within the liver cell, as CPS I and OTC are co-localized in the mitochondria while 
the remaining enzymes are situated in the cytosol (Figure 1.1 ). 
The first step in ureagenesis involves the CPS I reaction in which ammonia and 
bicarbonate are combined to form carbamoyl-phosphate. This is an energetically demanding step 
where two ATP molecules are required to facilitate the formation ofthe product. Carbamoyl-
phosphate is released into the mitochondrial matrix where OTC can utilize it along with 
2 
NH3 + HC03- + 2 ATP 
1 CPSI 
H2N-CO-P03-
Mitochondria Cytosol 
Carbamoyl phospbate 
HN-CO-NH2 
I 
CH2 
I 
CH2 
I 
CH2 
I + CH-NH3 
I 
c5/c'o· 
Citrulline 
NH2 
I 
c=o I 
NH2 Arginase 
Urea 
ASL 
.. 
Fumarate 
ASS 
Arginine Argininosuccinate 
Aspartate 
Figure 1.1: Compartmentalization of Urea Cycle Enzymes. Carbamoyl-phosphate 
synthase I (CPS I), Ornithine transcarbamoylase (OTC), 
Argininosuccinate Synthetase (ASS), Argininosuccinate Lyase (ASL) and 
Arginase. 
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ornithine, to produce citrulline. These enzymes, through the use ofimmuno-electronmicroscopy, 
have been found to be loosely associated with the inner membrane of the mitochondria ( 41 % of 
CPS I and 59% ofOTC are located within 15 run ofthe cristae) (Powers-Lee and Corina, 1987; 
Yokota and Mori, 1986). It is believed that these enzymes are in close proximity with one 
another and that this localization allows for more efficient exchange of intennediates (Powers-
Lee and Corina, 1987; Watford, 1991). OTC has also been reported to be closely associated with 
the mitochondrial ornithine-citrulline antiporter (Cohen et aL, 1987). This antiporter moves 
ornithine from the cytosol into the mitochondria in exchange for a citrulline molecule. This leads 
to constant removal ofOTC's product while providing the necessary substrate for further flux 
through this enzyme. 
The first cytosolic reaction occurs when citrulline reacts with aspartate in the ASS-
--catalyzed·reactionto form argininosuccinate: This reaction involves1ln;rincotpotation-or-the 
second nitrogen through aspartate. Argininosuccinate can then be cleaved into arginine and 
fumarate by ASL. Fumarate is recycled to form aspartate in the cytosol while arginine is cleaved 
by arginase into ornithine and urea. Ornithine can be transported back into the mitochondria to 
become the substrate for OTC, thereby beginning another cycle. Urea, the other product of 
arginase, can now be released into the blood stream where 60-70% is filtered by the kidneys and 
released from the body in the urine. The remainder is degraded by microbial urease in the 
intestine (Metges, 2000). Jackson et al. (1993; 1995) stated that the colon can salvage urea 
nitrogen and that this nitrogen can be incorporated by intestinal microbes into amino acids that 
are then absorbed by the host. Although this certainly occurs, its quantitative importance in tenns 
of amino acid nutrition has been debated. 
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Occurrence of Urea Cycle Enzymes Outside the Liver 
In mammals, the liver is seen as the central site ofureagenesis as it contains all the 
enzymes involved in that cycle. These individual cycle enzymes, however, are not exclusively 
localized to the liver and have been found to exist in other tissues. For instance, the intestinal 
mucosa contains CPS I and OTC while ASS and ASL are found in the kidneys. The purpose of 
these partial pathways is the synthesis of arginine (in the kidney) from glutamine (converted to 
citrulline in intestinal mucosa) that can be used for such functions as protein synthesis and NO 
production (Dhanakoti et aL 1990). Furthermore, Wu (1995) identified that the enterocytes of 
post-weaning pigs had the capacity to synthesize urea from extracellular or intramitochondrially 
generated ammonia (Wu, 1995). This is the only other known existence of a complete urea cycle 
existing in mammalian cells other than liver cells. 
Regulation of the Urea Cycle 
Regulation of ureagenesis is essential in the maintenance of ammonia homeostasis 
within the body. Long-term regulation involves changes in the amount of enzyme protein while 
short-term regulation occurs when the activity of existing enzyme protein is altered. 
Long-term changes in the enzymatic concentrations of the urea cycle occur over a 
relatively extended period of time due to the quite long half-lives of these enzymes (on the order 
of days) (Watford, 1991; Meijer et aL 1990). This regulation is an adaptive mechanism that 
responds to alterations in amino acid nitrogen flux due to changes in dietary protein intake or 
catabolism of endogenous protein (Morris, 2002). Hormones (glucagon, insulin, and 
glucocorticoids) play a major role in mediating changes in activity under these conditions, 
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largely through altering the rate of transcription of the urea cycle enzymes (Morris, 2002). 
In addition, there is an essential role to be played by short-term regulation of the urea 
cycle. It has been shown that substrate availability is probably the most important influence on 
short-term changes in rates ofureagenesis (Beliveau et aL, 1993). CPS-I, which catalyses the 
initial, committed step in ureagenesis, has an absolute requirement for N-acetylglutamate as an 
allosteric activator. This activator is synthesized within the mitochondrion by N-acetylglutamate 
synthetase, and its levels have been reported to correlate with the rate of ureagenesis (Beliveau et 
aL, 1993; Stewart and Walser, 1980; Lund and Wiggins, 1987, Cohen et aL, 1982). It is the 
short-term regulation of CPS I, NAG production and subsequent flux through the urea cycle 
which will be the focus of my thesis. 
Carbamoyl;. Phosphate Synthase I 
As mentioned above, there exists one enzyme within the urea cycle, carbamoyl-phosphate 
synthase I, which requires an allosteric activator, N-acetylglutamate (NAG), to modulate its 
activity. This enzyme has also been identified as having a flux coefficient of= 1 for this 
pathway, which means that all of the flux control of the urea cycle is vested in this enzyme 
(Meijer et aL 1990). This enzyme belongs to a class of CPSases which differ in their substrates 
and activators. Other CPSases (CPS II and CPS III) use glutamine as the ammonia donor for 
carbamoyl-phosphate synthesis (McCudden and Powers-Lee, 1996). The inherent glutaminase-
like activities found in these enzymes have been lost in CPS I. However, a residual glutaminase 
domain remains in the protein structure but a mutation has occurred which has replaced an 
essential cysteine with a serine rendering the site inactive (Rubio et aL, 1983). It is the inability 
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to use glutamine as the nitrogen donor which distinguishes CPS I from the other CPSases. 
Purified CPS I has been shown to exist in a state of rapid, reversible monomer-dimer 
equilibrium (Lusty, 1978; Lusty 1981 ). The allosteric activator NAG displaces this equilibrium 
toward the catalytically active monomer form (160 kDa) (Lusty, 1978; Lusty 1981). Also, CPS I 
is the most abundant protein (15-26% of total matrix protein; concentration of 1-1.5 mM) in 
liver mitochondria and is thought to be loosely associated with the inner membrane together with 
another urea cycle enzyme, OTC (Lusty, 1981; Powers-Lee and Corina, 1987). This association 
with the inner membrane has been proposed as an effective means of channelling of 
intermediates between these two enzymes (Powers-Lee and Corina, 1987; Cohen et aL 1987; 
Watford 1991 ). 
The reaction catalyzed by CPS I occurs as a step-wise process. There exist two distinct 
. ·- ... . -· -· -- - Al'P-binding-sites-onthis--enzyme·referred·to·as domairrs-s··and-C(Simmer·etal·; -r99U;Rori!fer ···· · · ····· ·- · · ·-
aL, 1994; Lusty, 1983; Nyunoya et aL, 1985). The binding of ATP to these sites occurs in 
discrete steps in the reaction pathway. ATP 8 binds to domain B and activates the bicarbonate to 
accept the ammonia molecule (McCudden and Powers-Lee, 1996). Then, ATPc reacts with 
domain C and donates a phosphate group to the carbamide to form carbamoyl-phosphate 
(McCudden and Powers-Lee, 1996). The substrates which donate the carbon and nitrogen are 
specific as well. NH3 rather than NH4 + is the true substrate for this reaction, with a Km for NH3 
of38 J..LM.(Cohen et aL, 1985). Also, HC03- not C02 is the carbon donor, with bicarbonate (Km 
= 4-5 mM) being preferentially supplied by the enzymatic reaction of carbonic anhydrase. This 
enzyme scavenges C02 released in the mitochondria via the citric acid cycle and converts it to 
bicarbonate (Dodgson et aL, 1983). 
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Regulation of Carbamoyl-phosphate Synthase 
The regulation of CPS I is mediated by its absolute requirement for N -acetyl glutamate 
(NAG). This activator is produced within liver mitochondria by the enzyme N-acetylglutamate 
synthetase (NAGS) which catalyses the following reaction (Shigesada et al., 1978): 
Acetyl CoA + Glutamate :::::> N-acetylglutamate + CoASH 
Mitochondrial production ofNAG is the only source of this regulator for CPS I, as cytosolic 
NAG is impermeable to the outer mitochondrial membrane (Meijer and Van Woerkom, 1978). 
The catabolism of NAG depends on transport out of the mitochondria and deacylation in the 
cytosol (Meijer and Van Woerkom, 1978). 
NAGS exists as a trimer with a molecular weight of 160 }d)a. The ~ for glutamat_e is 3 
~ -- ~ . . .. . - - - - . - ~ . '-
mM and the Km for acetyl-CoA is 0.7 mM (Souba and Tatibana, 1983). Arginine has been 
reported to be a potent activator of NAGS (Ka = 5-10 mM) (Shigesada et aL, 1978). Long-term 
exposure to saturating arginine concentrations increased the activity of NAGS by increasing the 
Vmax without altering the Km for substrates (Morimoto et aL, 1990; Shigesada et aL, 1978; 
Kawamoto et aL, 1985). Short-term changes in arginine concentration did not exhibit similar 
results. Stewart and Walser (1980) injected amino acids mixtures (20 amino acids) into rats to 
observe short-term changes in ureagenesis. They reported that the increase in NAG was not 
attributable to increased activation of NAGS by arginine. As arginine levels increased within the 
liver, the activity ofNAGS remained unchanged (Stewart and Walser, 1980). These results 
suggested that moderate loads of amino acids activated ureagenesis via a rapid increase in NAG 
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levels, which were secondary to the increase in hepatic glutamate content, and independent of 
arginine stimulation ofNAGS (Stewart and Walser, 1980). Since acute changes in mitochondrial 
NAG in response to an amino acid load are not a result of the activation ofNAGS, there must be 
some other mechanism to account for this phenomenon. One suggestion is that the sudden 
increase in the liver concentration of glutamate, as seen by Stewart and Walser (1980), may play 
an important role in NAG synthesis. 
Mitochondrial NAG levels have been shown to be positively correlated with the rate of 
mitochondrial citrulline synthesis by a number of researchers (Beliveau et aL, 1993; Stewart and 
Walser, 1980; Lund and Wiggins, 1987, Cohen et aL, 1982). This correlation has been shown to 
occur in response to acute changes in ammonia levels such as after a single protein meal or 
shortly after an ip injection of an amino acid mixture (Beliveau et aL, 1993; Stewart and Walser, 
1980);-ln addition,-the half-life--of NAG is-approximately 20--minutes.as.it is transported_out of. . 
the mitochondria for deacylation (Meijer and Van Woerkom, 1978; Morita et aL, 1982). Thus, 
changes in NAG content can be achieved quickly compared with the time required to increase the 
protein concentration of urea cycle enzymes. It is believed that short-term control ofureagenesis 
can be mediated through regulation of NAG levels in the mitochondria. 
One molecule of NAG is bound per molecule of CPS I; this results in complete activation 
of the enzyme. This activator binds to CPS I via the C-terminal end of the protein which changes 
the conformation of the enzyme (Rodriguez-Aparicio et aL, 1989). Previously, it had been 
suggested that NAG bound in theN-terminal end in proximity to the residual non-functional 
glutaminase subunit but this theory was discarded after radio-labeled experiments (cleaved 
portions of CPS I were incubated with U- 14C- NAG) proved that the C-terminal end was key in 
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the binding of this activator (McCudden and Powers-Lee, 1996). The importance, if any, of this 
residual non-functional glutaminase domain is still unknown. The binding ofNAG to CPS I 
facilitates the binding of A TP 8 to domain B by inducing a conformational change in CPS I which 
exposes essential S-H groups at Domain B; it does not influence the binding of ATPc(Potter and 
Powers-Lee, 1993; Rubio et aL, 1983). 
The kinetic relationship between this enzyme and activator has been described as positive 
V- type allosteric kinetics (Lusty, 1981). This type of regulation, as described by Monod and 
Wymann (1965), involves an allosteric ligand which exerts a direct effect on the catalytic activity 
rather than on the affinity of the enzyme for its substrates and implies that cooperative substrate 
interaction should not be observed (Monod and Wymann, 1965). 
Throughout the literature, there have been disagreements on the exact relationship 
relationship between rat liver mitochondrial NAG levels and the rate of mitochondrial citrulline 
synthesis. Their experiment measured acute changes in NAG levels and citrulline synthesis in 
rats exposed to an ip load of different mixtures of20 amino acids. They reported aKa of0.8 mM 
for NAG which corresponds to half the concentration of CPS I in the mitochondria (Stewart and 
Walser, 1980). This hyperbolic relationship was also reported by Lund and Wiggins (1987). 
They analysed CPS I activity in freeze -thawed mitochondria as a function ofNAG 
concentration. The Ka reported varied depending on the isolation and assay techniques employed 
(Lund and Wiggins, 198 7). In contrast, Morimoto et aL ( 1990) reported a linear relationship 
between NAG and CPS I up to 1.5 mM mitochondrial concentration of NAG. Their study 
investigated three test groups of rats which were fed different protein diets for 24 hours ad 
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libitum (Morimoto et aL, 1990). These results were also supported by Rabier et aL (1982) who 
found a similar linear relationship when rats were exposed to glucagon for extended periods. 
Although discrepancies exist, the hyperbolic relationship was reported to occur in experiments 
where short-term changes in either ureagenesis or NAG levels were measured. 
As previously mentioned, short-term changes in ureagenesis correspond to increased 
NAG levels but not an increase in NAG synthase activity (Stewart and Walser, 1980). Therefore, 
it is plausible that the limiting factor is substrate availability. As mentioned previously, Stewart 
and Walser (1980) showed a direct correlation between the glutamate concentration and the 
amount of NAG within liver mitochondria. We intend to investigate whether glutamate produced 
through the hydrolysis of glutamine by liver-type glutaminase, another mitochondrial enzyme, 
has any influence on the production of NAG within the mitochondria. 
Glutamine Metabolism 
Glutamine is a nonessential amino acid which plays an important role in the interorgan 
transport of nitrogen and carbon in mammals. It is the most abundant amino acid in the blood, 
and accounts for about 113 the circulating amino acid nitrogen (Brosnan et aL, 1983; McGivan 
and Lynch, 1988). Glutamine serves as a key substrate for renal ammoniagenesis, an important 
precursor for pyrimidine, purine, NAD+, and glucosamine synthesis, and a substrate for 
gluconeogenesis and ureagenesis in the liver (Souba, 1991). Synthesis of this amino acid 
scavenges free ammonia which serves to protect the brain against toxic side effects. 
The intracellular metabolism of glutamine is regulated by two key enzymes. The 
synthesis of glutamine is carried out by the enzyme glutamine synthetase which utilizes a 
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glutamate and an ammonia molecule to form glutamine. Skeletal muscle and lung which 
synthesize and release net amounts of glutamine have substantial amount of this enzyme (Souba, 
1991 ). On the other hand, the catabolism of glutamine is catalyzed by the enzyme glutaminase 
which hydrolyses glutamine to glutamate and ammonia. Replicating cells such as enterocytes, 
lymphocytes, reticulocytes, oocytes, and cancer cells contain greater activities of glutaminase as 
they tend to be large consumers of this amino acid (Souba, 1991). The liver has the capacity to 
consume or release net amounts of glutamine. 
Heterogeneous Distribution of Glutamine Metabolism in Liver 
In the liver acinus (functional unit of liver), the periportal and perivenous regions differ in 
the expression of enzymes and, consequently, in metabolic functions. Haussinger (1998) (Figure 
_ ___ __ _ ___ . 1.2) has __ described three-separate zones-o:fammonia and glutami-ne metabolism.-The first zone 
(Zone 1) is found in the periportal region (sinusoidal inflow) and it contains the enzymes that are 
involved in ureagenesis and glutamine catabolism. Within this zone, circulating ammonia and 
ammonia released from the catabolism of glutamine can be detoxified through the urea cycle. 
The second zone described by Haussinger (1998) was Zone 2, which lies in the middle of the 
liver acinus, between the periportal (sinusoidal inflow) and perivenous (sinusoidal outflow). This 
zone also contains the enzymes of the urea cycle and can further remove toxic ammonia from 
circulation. The last zone described was Zone 3, which is located in the 
perivenous end of the liver acinus which contains the enzyme glutamine synthetase (Haussinger, 
1998). The location ofthis enzyme allows for circulating levels of ammonia to be scavenged by 
the perivenous cells and assimilate it along with glutamate into a less toxic carrier, glutamine. 
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Figure 1.2: Organization of Hepatic Glutamine and Ammonia Metabolism. The 
metabolic zones and enzyme localization within the liver, as depicted 
above, were described by Haussinger (1998). The legend illustrates those 
enzymes that play an essential role in hepatic glutamine and ammonia 
metabolism. 
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Figure 1.2 depicts this zonation of ammonia and glutamine metabolism. 
These enzyme distributions serve a physiological function in ammonia metabolism. The 
localization of glutaminase and the urea cycle together at the inflow allows for effective 
metabolism of amino acid nitrogen. As mentioned previously, glutamine is the most abundant 
amino acid in the blood, and accounts for about 113 the circulating amino acid nitrogen (Brosnan 
et al., 1983; McGivan and Lynch, 1988). The breakdown of glutamine mediated by glutaminase 
will provide ammonia for immediate detoxification via the urea cycle. The presence of glutamine 
synthetase in the perivenous region allows for excess toxic ammonia to be scavenged from the 
blood and a non-toxic carrier glutamine is produced. This glutamine, in tum, can be carried to 
other parts of the body or circulated back to the periportal region. The hepatic catabolism of 
glutamine and its link to ureagenesis is the central focus of my thesis. 
Glutamine Transport 
The transport of glutamine into the liver occurs through a liver specific sodium-dependent 
transporter referred to as System N (Kilberg et al. 1980). This transporter has specificity for two 
other amino acids, asparagine and histidine (Tamarappoo et al. 1994). System N is composed of 
alOO-k.Da plasma membrane protein that mediates the transport of these amino acids 
(Tamarappoo et al. 1994). Glutamine can also be transported via System A, but this only 
constitutes 5-l 0 % of total hepatic glutamine transport (Low et al. , 1990). While the influx of 
glutamine into the liver is performed by System N, the efflux is regulated by another transporter 
which is Na+-independent and termed "System n" (Pacitti et al. 1993). It is believed that System 
n is involved in the facilitated diffusion of glutamine from hepatocytes in the perivenous region 
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of the liver. 
The transport of glutamine via System N can be induced by prolonged exposure to insulin 
and glucagon (Gebhardt and Kleeman, 1987) but short-term hepatocyte incubations with these 
hormones do not induce changes in System N activity (Kilberg et aL, 1980). Diabetes 
(streptozotocin-induced) caused an increase in System N activity in isolated hepatocytes (Barber 
et aL, 1982) but not in isolated sinusoidal membrane vesicles (Low et aL 1992). The opposite 
effect was seen with corticosteroid treatment of rats which induced glutamine transport in 
sinusoidal membrane vesicles (Low et aL, 1992). Regulation is also mediated by the extracellular 
pH, as a decreased pH resulted in lowered glutamine uptake (Lenzen et aL, 1987). 
Work on glutamine transport revealed that steady state glutamine concentration gradients 
are built up within the liver (Haussinger et aL, 1985; Lenzen et aL, 1987.; Remesy et aL, 1988). 
-- -·-·-- -· · - -The physfoTogicarcoticentration ofglutaminei n ·the portalvein-is·0~6 mM·while within ihe-· -- -··---- · ---··--··---
cytosol of the liver it is 4-6 mM and 20 mM in the mitochondrial matrix (Haussinger et aL, 
1985a). Haussinger et aL (1985b) found that histidine at near physiological concentrations 
inhibits influx (periportal) and efflux (periportal) of glutamine in the liver. This group continued 
to study the influence of transport inhibition by histidine on the metabolism of glutamine in 
isolated hepatocytes. It was determined that System N had a flux control coefficient of 0.31 for 
glutamine catabolism. This suggests that glutamine transport is involved in the regulation of 
hepatic glutamine metabolism. 
Glutaminase 
History 
Glutaminase was first identified by Hans Krebs in 1935, when his analyses of 
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mammalian extracts from a number oftissues demonstrated the capacity to hydrolyse glutamine 
into glutamate and ammonia (Krebs, 1935). Further work allowed Krebs to describe two 
glutaminases which are distinguishable by their optimal pH and inhibition by glutamate. The two 
isozymes were originally referred to as brain-type (now referred to as kidney-type) and liver-type 
glutaminase. It is now evident that differences exist not only in kinetic properties but also protein 
structure as the enzymes are the products of two different but related genes (Smith and Watford, 
1988). 
Studies on the localization of glutaminase within various tissues have shown that it is a 
mitochondrial enzyme. Guha's work on liver mitochondria identified glutaminase activity within 
this organelle (Guha, 1962). Other studies have found similar results for glutaminase in the 
kidney, brain, and intestine (Kvamme etaL, 1991; Curthroys and Weiss, 1974). The location 
___ within the mitochondria-was further studied· by K:alra and-Brosnan-(1973). Theiffise of -- ----- -- . -- -- --- ---
detergents and sonication methods to disrupt liver mitochondria showed that glutaminase was 
released to the same extent as mitochondrial matrix markers. They suggested that glutaminase 
must be located in the mitochondrial matrix (Kalra and Brosnan, 1973 ). McGivan et aL (1980) 
furthered the study on localization by the use of freeze thawing to disrupt liver mitochondria. 
Their work suggested that liver glutaminase was associated with the mitochondrial membrane 
fraction. Curthoys and Weiss (1974) furthered the investigation on the submitochondrial 
localization of glutaminase through their use of digitonin and fractionation methods. Their 
studies led to the discovery that glutaminase was loosely associated with the inner surface of the 
inner membrane of mitochondria. 
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General Properties 
Glutaminase (L-glutamine amidohydrolase) (EC 3.5.1.2.) is referred to by a number 
names such as glutaminase I, phosphate activated glutaminase, and /or phosphate-dependent 
glutaminase. This enzyme catalyses: 
L-glutamine + H20 => L-glutamate· + NH4 + 
There are two isoenzymes of glutaminase which perform this irreversible reaction. This 
distinction was first made by Krebs in 1935 (Krebs, 1935). 
Kidney-Type 
The kidney-type isozyme of glutaminase is widely distributed among glutamine utilizing 
tissues such as the kidne}', brain, intestine, heart, skeletal muscle and lung. In addition, this 
------ ----- --------------------- - ---- - -------------- ------ -------------- --- -------------- ---- ----·-- ------ -- ------ -- --- ·--- --- ------ ---·----------···- --------------------------- -------- - --
enzyme is found in the liver during fetal development but is not present in the adult liver 
(Curthoys and Weiss, 1974). Reports of the Km for glutamine vary slightly depending on the 
tissue location of the enzyme. The kidney enzyme has a Km of 4 to 5 mM, within the brain the 
Km is 2 to 8 mM and in the intestine the Km is about 2.2 mM (Klingman and Handler, 1958;, 
Svenneby et aL, 1973; Pinkus and Windmueller, 1977). This isozyme of glutaminase is activated 
by inorganic phosphate (Ka = 20-30 mM) (Errera and Greenstein, 1949; Curthoys and Watford, 
1995) and inhibited by its end-product, glutamate. Kinetic studies performed on glutamate' s 
inhibition showed that it exhibits non-competitive inhibition with respect to glutamine and 
exhibits competitive inhibition in relation to inorganic phosphate (Sayre and Roberts, 1958). 
These results show that glutamate inhibits the function of this enzyme by occupying the binding 
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site of phosphate rather than the binding site of glutamine. 
The activity of kidney-type glutaminase can be influenced by a number of other 
metabolites and compounds. Studies involving a number of sulfhydryl blocking agents such as 
mercuric chloride, mersalyl, and 3,3'- dithiobis[6-nitro-]benzoic acid have shown their capacity 
to inhibit this enzyme (Kvamme et aL, 1970). Also, the leucine analog 6-diazo-5-oxo-L-
norleucine has been shown to be an effective inhibitor of this enzyme (Conti and Minelli, 1994; 
Shapiro et aL, 1979). Activation of this isozyme has been noted to occur in the presence of a 
number of metabolites. ATP, ADP, ITP, CTP, and some carboxylic acids such as malate, 
succinate, and a-ketoglutarate have exhibited the ability to activate this enzyme (Kovacevic and 
McGivan, 1983). It should be noted that activation by these metabolites occurs at concentrations 
which are not of physiological relevance. The activity of renal glutaminase has also been shown 
to increase in-response-to metabolic-acidosis (€urthoys ·et aL-;-1984) , streptozotocin•induced -
diabetes (Lemieux et aL, 1984}, and long term feeding ofhigh protein diet (Brosnan et aL, 1978). 
Liver- Type 
The liver-type glutaminase, unlike the kidney-type, is only found in the postnatal liver 
and accounts for nearly all of the glutamine catabolized within the liver (Low et aL , 1993). As 
mentioned previously, it is loosely associated with the inner membrane of the mitochondria. The 
kinetic properties ofliver type glutaminase are different from kidney-type. For instance, liver-
type glutaminase has a relatively high Km (17 mM) for glutamine, a lower Ka for phosphate and 
a pH optimum from 7.8 to 8.2 (Smith and Watford, 1988). Also, liver-type glutaminase is not 
inhibited by its end-product glutamate (Krebs, 1935). However, -SH blocking agents which 
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inhibit kidney-type glutaminase also inhibit the activity of the liver-type glutaminase (Joseph et 
aL, 1981 ). Its activity has also been reported to be inhibited by a number of amino acid analogs 
such as N-acetylglutamine and 6-diazo-5-oxo-L-norleucine (Conti and Minelli, 1994). 
Purification has shown that this enzyme has an apparent subunit molecular mass of 58 kDa 
(Smith and Watford, 1988). 
Short Term Regulation of Liver-Type Glutaminase 
Liver-type glutaminase has another regulatory property which distinguishes it from other 
glutaminases as it is activated by its end-product, ammonia. This phenomenon was first 
identified by Charles (1958) in intact mitochondria, in isolated hepatocytes by Joseph and 
McGivan (1978) and in perfusion studies of rat livers (Haussinger et aL, 1983). These studies 
---------··-··-·- --- --··· --- --- --- --·--- ---------- ····-
.. --· . --·--- .. -·-sliowcii" iliafammorua" mfluence(f the acflvity"ofiiie enzymebut neveridentified whether the 
ammonia was working directly on the enzyme or by some other indirect mechanism. Work 
performed on disrupted mitochondria where the enzyme is exposed directly to the substrate 
demonstrated that ammonia evokes its effect directly on the enzyme (McGivan and Bradford, 
1983). In perfused rat liver, the activation of glutamine hydrolysis is half-maximal at 0.2 - 0.3 
mM NH/ (Haussinger and Sies, 1979). This activation of glutaminase by NH4Cl is of 
physiological relevance as the portal vein ammonia concentration has been measured to be 
approximately 0.6 mM (Haussinger and Sies, 1979). 
It has been proposed by Welbourne (1987) that the ammonia activation of glutaminase is 
an interorgan "feed-forward" system. Ammonia produced from intestinal catabolism of 
glutamine would ensure that the liver would be able to deal with increased glutamine absorption 
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from the diet by activating glutaminase (Welbourne, 1987). This system would allow the liver to 
maintain homeostasis during fluctuations in dietary uptake. Experimentally, "feed-forward" 
activation of glutamine by ammonia was first identified by Haussinger et aL (1975). His study 
involved the perfusion of 5 mM glutamine through rat livers and he discovered that glutamine 
catabolism occurred after a lag period of30 minutes. This was interpreted by Haussinger et aL 
(1975) as the time required for self activation through end-product accumulation. A brief 
perfusion of ammonia prior to the perfusion with glutamine showed no lag period in glutamine 
catabolism. This quick response to ammonia illustrates the importance of this end-product in the 
regulation of liver-type glutaminase activity. 
Glutamine catabolism in the liver is also influenced by a number of hormones and other 
metabolites. Hormones such as glucagon (Brosnan et aL 1995), adrenaline, angiotensin II, 
------ -catechoianunes -andvasopiessm-(Corveriana GarCia~Samz~-f983)liave-oeen reportoo-toquiCidy --------- -----
activate glutaminase. Mitochondria isolated from rats which were exposed to these hormones 
have altered metabolism compared to mitochondria isolated from control (saline-injected) rats. 
Increases in mitochondrial adenine nucleotides, membrane potential, matrix volume, pH 
gradient, citrulline synthesis, and alteration in mitochondrial respiratory rates have been reported 
after glucagon injection (Halestrap et aL, 1986). Halestrap has argued that activation by these 
hormones occurs via mitochondrial swelling (Halestrap 1989), as similar results were illustrated 
by incubating mitochondria in hypotonic media. However, the precise link between the signaling 
pathway of these hormones, the altered metabolic conditions and the activation of glutaminase 
has yet to be elucidated. 
Brosnan et aL (1995) studied the glucagon signaling pathway in glutaminase activation. 
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Their study showed that glutaminase was activated by a cell permeable protein kinase A activator 
(Sp-cAMPS) and by a cell permeable protein phosphatase 1 and 2A inhibitor okadaic acid. 
However, the activation of glutaminase by glucagon was not inhibited by a protein kinase A 
inhibitor. This study, alone, illustrates the complexity and redundant elements that may be 
involved in the signaling pathway of hormones in the activation of glutaminase. 
Objectives of this Study 
The intent of this study is to investigate whether liver-type glutaminase plays a indirect 
role in ureagenesis through its effect on NAG production. As mentioned previously, NAG is an 
essential activator of CPS I which is the rate limiting step of the urea cycle. Hepatic glutaminase 
is believed to be associated with the urea cycle but the nature of this association is not fully 
understood. My hypothesis is that hepatic glutaminase provides glutamate for N-acetylglutamate 
synthesis (Figure 1.3). Therefore, factors which influence glutaminase activity should activate 
CPS I by increasing NAG levels. We intend to investigate known activators ofliver-type 
glutaminase (1 mM NH4Cl and 1 o-7 M glucagon) in perfused rat livers and isolated hepatocytes 
to examine their influence on mitochondrial NAG levels. From the perfused livers and isolated 
hepatocytes, we shall prepare mitochondria and measure both the rate of citrulline synthesis and 
concentration of NAG within the mitochondria. These measures will allow us to assess the 
influence ofliver-type glutaminase activators on mitochondrial NAG levels. 
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Figure 1.3: Proposed Involvement of Liver-type Glutaminase in the Regulation of 
the Urea Cycle •. 
22 
Chapter Two 
Materials and Methods 
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MATERIALS 
Chemicals 
Collagenase A, glutamate dehydrogenase in glycerol and bovine serum albumin 
(prepared from fraction V, essentially fatty acid free) were obtained from Boehringer-Mannheim 
(Laval, Quebec). [l -14C] Glutamate was from Dupont New England Nuclear (Mississauga, 
Ontario). Toluene and Omnifluor were purchased from Fisher Scientific (Nepean, Ontario). 
QAE Sephadex A-25 was from Pharmacia LKB (Baie D'Urfe, Quebec). Glucagon was obtained 
. -·-~··- . -· . - ~ ·----- -- -·--- ---- ·---· --· ------ - -- . ··--- ---·-- ----··-··--·- •.. --- ·-· - - · - . . ·-·- --- --· · - ---
from Sigma (St. Louis, USA). All other chemicals were obtained from Sigma and were of the 
highest grade available. 
Preparation of [1-14C] glutamine 
To prepare [l_t4C] glutamine from [1_t4C] glutamate, a 15 000 x g supernatant from a rat 
liver homogenate of one part tissue plus three parts 0.9% NaCl was used as a crude preparation 
of glutamine synthetase. The incubation was for 3 hours at 37° C. The incubation mixture, in a 
final volume of0.5 ml, consisted of: Tris/HCl buffer, pH 7.4 (78 mM); 15.6 mM NH4Cl; 15.6 
mM MgC12; 7.8 mM ATP; 5.6 mM [1-14C] glutamate; 7.8 mM phosphocreatine; 10 units /ml 
creatine kinase and 0.1 ml of liver sample in 0.5 ml incubation mixture (0.2 ml /ml) (Baverel and 
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Lund, 1979). At the end of the incubation, the mixture was deproteinized with 0.05 ml of 10% 
perchloric acid (w/v). The pH was adjusted to 7.0 using 50% K2C03 (w/v). [1-14C] Glutamine 
was separated from any unreacted [l-14C] glutamate by column chromatography using Sephadex 
QAE. This is an anion exchanger that will bind glutamate but not glutamine. This gel has been 
equilibrated with 40mM Tris-HCl, pH 5.7 (Haussinger et aL, 1983). The radioactivity of our 
sample was assessed before adding to the column. This was performed by placing 10 J.tl of our 
sample in Scintiverse and measuring the radioactivity using a LKB Wallac liquid scintillation 
counter. The sample was placed onto the column and 2 ml fractions were collected. The 
fractions were analysed for radioactivity, and those with positive results (tubes 13-20) were 
pooled and freeze dried. The samples were resuspended in H20 (approx. 25 ml) and were, once 
again, freeze- dried and stored in the freezer. 
··- ·-·· -····· ··-
-H - -· --H ·-- --- -·· 
Animals 
Male Sprague-Dawley rats weighing 250-350g were obtained from Memorial University 
breeding colony. Animals had access to water and Purina chow (Ralston Purina of Canada, Don 
Mills, Ontario) ad libitum. All procedures were approved by the President's Committee on 
Animal Bioethics and Care of Memorial University and were in accordance with the guidelines 
of the Canadian Council on Animal Care. 
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METHODS 
Rat Liver Perfusion 
Rats were anaesthetised by i.p. administration of 0.3 ml of sodium pentobarbitol (0.1 mV 
1 OOg body weight). The femoral vein was exposed and 0.1 ml of heparin (1 000 Units /ml) was 
injected. Rat livers were then perfused in situ in non-recirculating mode as described by Sies 
(1978) with 2.1 mM lactate and 0.3 mM pyruvate present in the perfusate (Krebs-Henseleit 
medium) as respiratory substrates. The flow rate in all cases was approximately 40 ml/minute; all 
media were gassed with 0 2: C02 (95:5) for 20 minutes prior to use and gassing continued 
throughout the perfusion. NH4Cl (1 mM), 10-7 M glucagon, and/or 1 mM glutamine were added 
to the perfusate as stimulants of glutaminase activity. The perfusion was allowed to run for 75 
minutes; then the liver was removed and mitochondria prepared as described below. 
Preparation of Intact Mitochondria 
Each rat was killed by cervical dislocation and the liver rapidly removed and immersed in 
an ice-cold isolation medium that was modified from Hampson et aL (1983). This medium 
consists of mannitol (225 mM); sucrose (75 mM); ethyleneglycolbis-(P-aminoethyl ether) 
N,N,N',N'-tetraacetic acid (EGTA) (1 mM); and N-2-ethanesulphonic acid (Hepes) (5 mM); pH 
7.4. The method, essentially that of Jois et aL (1989), required that the liver be quickly and finely 
minced with scissors and then homogenized in 19 volumes of cold medium in a hand-held teflon, 
Potter-Elvejhem homogenizer, clearance of - 0.3 mm. The homogenate was then centrifuged in a 
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Beckman J2-MC centrifuge (JA- 20 rotor) at 600 g for 10 minutes at 4° C to pellet any 
erythrocytes, connective tissue, etc. The subsequent spins were carried out at 8200g. The second 
centrifugation provided a crude mitochondrial pellet that was re-suspended in isolation medium 
with one or two passes of a Dounce homogenizer. The mitochondria were purified by 
centrifuging this suspension at 8200 g for 10 minutes, re-suspending the pellet, and then 
repeating this procedure. A standard biuret procedure was used for detennining the protein 
concentration of the mitochondrial suspension (Gomall et aL, 1949). Bovine serum albumin 
(BSA) was used as standard. 
Respiratory Control Ratio and Succinate Oxidation 
Mitochondrial oxygen uptake was measured using a Clark-type electrode (Estabrook, 
------------- -- - - -----
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---------------- -I 967) in a medium which contained: 140 mM KC1; 4 mM KH2P04; 1 mM EDTA; 2.5 mM 
MgC12; 5 mM Hepes; 1 mglml BSA; pH 7.4 at 30°C. The medium was equilibrated with air. 
Mitochondria (1-2 mg mitochondrial protein) were incubated in this medium with 5 mM 
succinate and state 3 respiration was begun by addition of ADP (0.26 mM; final concentration). 
The mitochondria were accepted if they exhibited respiratory control ratios (State 3/ State 4 
respiration) of greater than 3. 
Flux Through Glutaminase in Intact Mitochondria 
Isolated mitochondria were incubated in 25 ml Erlenmeyer flasks for 10 minutes at 30°C. 
All incubations were in triplicate and each flask contained 2 mg mitochondrial protein and a 2.0 
ml fmal volume. The incubation medium consists of 100 mM KCl, 20 mM L-glutamine, 5 mM 
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succinate, 10 mM KH2P04, 1 mM EGTA, 20 mM Tris, 10 mM KHC03; pH 7.4 (Lacey et aL, 
1987). Rotenone was also present in the incubation medium to prevent further glutamate 
oxidation. After 10 minutes, the reaction was stopped with 0.3 ml of perchloric acid (7 % w/v). 
For zero time samples, 0.3 ml ofperchloric acid was added before the mitochondria. The protein 
was removed by centrifugation in an Eppendorfmicrocentrifuge for 2 minutes at 12,000 x g. The 
supernatant was taken and adjusted to pH 8.8 with 3 M K3P04 and was used for the glutamate 
assay (Bernt and Bergmeyer, 1974). Glutamate formation was calculated as the difference 
between the total flask content of glutamate at zero time and after the 1 0 minute period of 
incubation. The amount of glutamate formed was therefore a measure of flux through 
glutaminase. 
Glutaminase Assay in Freeze-thawed Mitochondria 
Glutaminase is located within the mitochondrion and, to assay its activity, disruption of 
the mitochondrial inner membrane is required. This is achieved by three cycles of freezing the 
mitochondria in liquid nitrogen followed by thawing in warm water (less than 37 ·c). The 
freeze-thawed mitochondria were then incubated for 10 minutes at 37 ·c in an incubation 
medium which consisted of 300 mM mannitol, 20 mM L-glutamine, 0. 7 mM NH4Cl, 20 mM 
Hepes, and 20 mM KH2P04;pH 7.4 (Szweda and Atkinson, 1990). The final volume was 1.0 ml 
with a final concentration of 1 mg /ml freeze-thawed mitochondria. The incubation was 
terminated by the addition of 0.3 ml of 7 % HC104 (w/v). The supernatant was adjusted to pH 8.8 
with K3P04 and glutamate was determined by using an enzymatic assay, employing a glutamate 
dehydrogenase assay (Bernt and Bergmeyer, 1974). This assay measures glutamate levels 
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through the conversion of glutamate and NAD+ to ketoglutarate and NADH. The increase in the 
absorbency at 340 run (measured using UV-vis) resulting from the reduction ofNAD+ to 
NADH, gives an accurate assessment of the amount of glutamate in our samples. 
Preparation of Hepatocytes 
Hepatocytes were prepared essentially as described by Krebs et aL ( 197 4) except that 
hyaluronidase was not present in the perfusate. Rats were anaesthetised by i.p. administration of 
0.3 ml of sodium pentobarbitol (0.1 mV 1 OOg body weight). The femoral vein was exposed and 
0.1 m1 ofheparin (1000 Units /ml) was injected. The isolation ofhepatocytes involves a two step 
perfusion of the liver. First, the liver was perfused with 500 ml of calcium-free K.rebs-Henseleit 
bicarbonate medium containing 2 mM EGT A, 20 mM glucose, 2.1 lactate, and 0.3 mM pyruvate. 
·--- - -----------~---- --------
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·------ --- ------Tlie-flow rateTnall cases wasapproxTmatefY.4o ml/minute; all media were gassed with 0 2: C02 
(95:5) for 20 minutes prior to use and gassing continued throughout the isolation procedure. The 
liver was then perfused with 500 m1 ofKrebs-Henseleit medium that contained 2.5 mM calcium, 
20 mM glucose, 2.1lactate, and 0.3 mM pyruvate. Calcium-containing Krebs-Henseleit medium 
with 2.5% BSA and 30 mg collagenase/100 ml was then recirculated for 15 to 20 minutes in a 
total volume of 200 ml. After the recirculation, the liver began to leak medium and was observed 
to break apart. At this point the liver was removed and minced in a petri dish. This suspension 
was then shaken in a Dubnoffmetabolic shaker at 37°C under 0 2 : C02 (95:5) for 10 minutes. 
The cells were spun at 30 g and washed two more times with Krebs-Henseleit medium. The final 
wash was in Krebs-Henseleit medium containing 2.5 % BSA and cells were also resuspended in 
this medium. Cell viability was determined by 0.1 % trypan blue exclusion and was greater than 
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95 % in all instances. Cells were quantified by determination of dry weight. A 3 ml aliquot of the 
cell suspension was placed in a pre-weighed metal weighing pan and a 3 ml aliquot of the 2.5% 
BSA resuspension medium was placed in a separate pre-weighed weighing pan. Both were 
weighed and dried in an oven at 50°C for 24 hours. The difference in weight of the cell 
suspension and the medium was used to determine the dry weight of the cells present in our 
suspension. 
Measurement of Flux through Glutaminase in Isolated Hepatocytes 
The procedure for determining flux through glutaminase involves the trapping and 
counting of 14C02 after incubation of cells with [l-14C] glutamine (1 mM) (Vincent et aL, 1989). 
This procedure has been shown previously by Brosnan et aL (1995) to be a valid measurement of 
- -
glutaminase flux. Incubations were performed in triplicate in 25 ml Erlenmeyer flasks containing 
between 4-6 mg dry weight ofhepatocytes at a final volume of 1 ml. Cells were preincubated in 
Krebs-Henseleit medium for 20 minutes at 37°C before addition of[1-14C] glutamine. Where 
indicated, 6-diazo-nor-leucine (DON) or glutamate-y-hydrazide were added during this 
preincubation. Also, in some incubations glucagon or ammonium chloride were added at the 
same time as [1-14C] glutamine. Each flask was gassed with 0 2: C02 (95:5) for 20 seconds after 
the addition of the cells and also after addition of [1-14C] glutamine. The incubation flasks were 
equipped with rubber septa in which empty plastic centre wells were suspended. NCS tissue 
solublizer was introduced into the centre wells through the septa just before termination of the 
incubation with 0.15 ml of30% (w/v) perchloric acid. 14C02 was collected for one hour and the 
centre wells were then transferred to scintillation vials containing 15 ml· of scintillation fluid 
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(Omnifluor) 
The cellular production of 14C02 was quantitated by a LKB Wallac liquid scintillation counter. 
Blanks included both zero time and zero protein incubations. 
Isolation of Mitochondria from Hepatocytes 
Hepatocytes were isolated from livers of fed rats as indicated previously. Two separate 
preparations ofhepatocytes were pooled. This was necessary in order to provide a sufficient 
amount of mitochondria. The pooled cells were resuspended in a final volume of90 m1 with 
Krebs-Henseleit medium containing 2.5 % BSA. The cells were then preincubated with or 
without 5 mM 6-diazo-nor-leucine (dissolved in DMSO) at 37"C under 0 2: C02 (95:5) in a 
-- shaking-bathfor-20-minutes: Glutamine (1 mM) was tlien added to each oftne flasks along with 
10·7 M Glucagon (dissolved in 10 mM HCl) andlorNH4Cl (1mM) and allowed to incubate for 
another 30 minutes. All concentrations listed are the final concentrations in incubation flasks. 
Along with incubations previously described, control incubations containing only glutamine 
(1mM) and with or without 5 mM DON were performed with each experiment. All incubations 
were in a final volume of 15 ml in a 50 ml Erlenmeyer flask which was gassed with 0 2: C02 
(95:5). The incubation was terminated by spinning the hepatocytes at 30 g for 2 minutes to 
remove the Krebs-Henseleit medium. A modification of a procedure used by Cervera and 
Garcia-Sainz (1983) was used to obtain the mitochondria. This method uses digitonin to disrupt 
the plasma membrane ofhepatocytes and permits the release of intact mitochondria. The cells 
were resuspended in isolation medium containing 0.255 M mannitol, 0.075 M sucrose, 5 mM 
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Hepes, 1 mM EGT A, 1 % BSA, and 0.4 mg digitonin/ ml (dissolved in DMSO). The cell 
suspension was kept on ice for 30 minutes with occasional inversion to resuspend the cells. This 
incubation in digitonin provides sufficient time for the chemical to adequately disrupt the plasma 
membrane. The cells were then subjected to a high-speed spin (8200 X g) for five minutes. The 
cell pellet was homogenized in digitonin-free isolation medium using 8-10 soft strokes of the 
Potter-Elvejhem hand-held homogenizer. The suspension was then subjected to the same 
procedure as used for the isolation of mitochondria from intact liver. Again, respiratory control 
ratios were checked using a Clark oxygen electrode with 5 mM succinate as a substrate and 
acceptable preparations had a ratio greater than 3. 
Citrulline Synthesis in Intact Mitochondria 
Flux through-the mitochondrial portion of the urea cyCle was measured by Incubation. of 
mitochondria in a 25 ml Erlenmeyer Flask placed in a Dubnoffmetabolic shaker at 30°C with a 
medium which comprised (final concentration): 80 mM KCI; 20 mM Tris (hydroxymethyl) 
methylamine (TRIS); 5 mM K 2P04; 5 mM succinate HCl; 20 mM KHC03; 5 mM NH4Cl; 20 mM 
L-ornithine; 1 mM EGTA; pH 7.4 in a final volume of 1.0 ml (Lacey et aL, 1987). The pH was 
adjusted using 0.1M NaOH. The final concentration of mitochondria was 3 mg protein /ml. The 
reaction was started by the addition of mitochondria, incubated for 6 minutes and then stopped 
by the addition of 0.3 ml of 30 % (w/v) perchloric acid. All incubations were done in triplicate. 
Citrulline produced during the incubation was assayed using the colorimetric method of 
Herzfeld and Raper (1976). The deproteinized supernatant of the incubation is first transferred to 
5 ml test tubes. Then 0.1 ml of the sample is added to a test tube containing 0.15 ml of H20. To 
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each of the tubes 3.0 ml of the chromogenic reagent was added and the tubes were mixed by 
inversion. The chromogenic reagent consists of 5.0 mg of thiosemicarbazide dissolved in 50 ml 
of diacetyl monoxime to which 100 ml of ferric acid solution was added. The tubes were 
incubated in a water bath at 1 OOOC for five minutes. They were removed, cooled, and absorbance 
was measured at 530 nm. 
Mitochondrial NAG Measurements 
Measurement ofN-acetylglutamate levels in isolated mitochondria was performed as 
described by Brosnan et aL (1996). Aliquots of mitochondria were deproteinized using 0.3 ml of 
perchloric acid (7% w/v). The protein was removed by centrifugation in an Eppendorf 
microcentrifuge for 2 minutes at 12,000 x g. The supernatant was taken and neutralized with 
_ . KOH~ Analyses _of samples were performed by Dr. Itzhak Nissim. at the University_ of. ... H --- - -- -- -- - - · 
Pennsylvania in Philadelphia, Pennsylvania, USA. N-acetylglutamatewas determined following 
separation from other amino acids present in the sample. This was done by applying a 500-J.Ll 
aliquot of mitochondrial extract to an AG-1 column (Cl" X-8; 100-200 mesh; 0.5 x 2.5 em). The 
column was washed with 3 ml of deionized water. NAG was eluted off the column with 3 rnl of 1 
N HCl. NAG concentrations were determined through the use of a modification of the 
conventional isotope dilution technique. GC-MS measurements were performed on a Hewlett-
Packard 5970 MSD coupled with a 5890 HP-GC. NAG enrichment in our sample was measured 
against a t-BDMS-derivative of 13C-NAG. 
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Determination of Ammonia (Phenol-Hypochlorite Method) 
Ammonia was determined by the phenol-hypochlorite method (Chaney and Marbach, 
1962). In a 10 m1 test tube, 0.5 m1 of the supernatant from the hepatocyte incubation was added 
along with 1 ml phenol colour reagent and 1 ml alkali-hypochlorite reagent. The phenol colour 
reagent was prepared by adding 50 g of phenol and 0.25 g of sodium nitroprusside to one litre of 
H20 and stored in an amber bottle. The alkali-hypochlorite reagent was prepared by the addition 
ofNaOH (25 g) and sodiwn hypochlorite (1g) to 1litre of H20. Samples were incubated in a 
shaker bath at 37°C for 20 minutes. After incubation, the samples were allowed to cool and their 
absorbance was measured at 630 nm. A standard curve for ammonia was also constructed and 
used to calculate ammonia concentration. 
Statistical Analysis 
All values are expressed as Mean ± SEM as indicated. Statistical analysis was executed 
by Graphpad Instat 3TM (Graphpad Software, San Diego, California, USA) and standard curves 
and graphs were produced using Graphpad (also of the Graphpad Software package). Both 
Student's t-test and the paired t-test were carried out using Instat 3TM, as indicated. Multiple 
comparisons were tested using ANOV A followed by Neuman-Keul 's post test and 3-factor 
analysis of variance was employed on the perfusion studies. Statistically significant differences 
were deemed to be P < 0.05. 
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RESULTS 
Rationale 
N-acetylglutamate is an essential activator of the enzyme carbamoyl-phosphate synthase I 
(CPS I) which is the rate limiting enzyme ofureagenesis (Hensgens et aL, 1980). Therefore, the 
rate of citrulline synthesis is markedly influenced by the mitochondrial concentration of NAG. 
This activator is produced by the mitochondrial enzyme N-acetylglutamate synthetase which 
catalyses the reaction of glutamate and acetyl-CoA to produce NAG and CoASH. 
Liver-type glutaminase, another mitochondrial enzyme, catalyses the hydrolysis of 
glutamine to glutamate and ammonia. The work presented here is focused on the investigation of 
ghitariiate, the product of glutaininase~ ilri.d its poteritiar role-in regulating· the urea· cycle. We 
suggest that the glutamate released from glutaminase will become the substrate for 
N-acetylglutamate synthetase. This will increase the mitochondrial concentration of CPS I's 
activator, NAG, and subsequent flux through the urea cycle. This activation of glutaminase should 
result in an increased rate of ureagenesis. 
Effect of Glutaminase Activation on N-Acetylglutamate Concentration 
Our initial experiments involved rat liver perfusions where known activators of 
glutaminase (glucagon and NH4Cl) and its substrate glutamine were introduced to examine their 
influence on mitochondrial NAG content and citrulline synthesis, which is a measure of flux 
through the first two enzymes of the urea cycle (CPS I and OTC). 
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When glucagon (10-7 M) was present in the perfusion, we found that the concentration of 
NAG in mitochondria increased significantly by 49 % (Figure 3.1 ). Correspondingly, the rate of 
citrulline synthesis within these same mitochondria also increased. These results of glucagon's 
influence on NAG production are consistent with previous work on this hormone (Rabier et aL, 
1982; Cathelineau et aL, 1982). 
When NH4Cl (1 mM) was perfused through the liver, there was a significant effect on the 
mitochondrial NAG content (100% increase; Figure 3.1) and a corresponding increase in the rate 
of citrulline synthesis. The effect ofNH4Cl suggests that this urea cycle substrate influences its 
own removal, in part, by increasing production of NAG. A similar effect of ammonium chloride 
on NAG levels had been reported by Zollner (1981) but that study used concentrations ofthe 
activator, ammonia, which were 10 times higher than those used here. Our study, at near 
-···· · ·-· ·-· ··· ···-- i>il:Ys1o1o~carconcentrations;--suggest8 ·that ilie-m.fiueiice <>rN'H~cr<>n-tlieiifea-cyCfe-activaior- -------- --·--------- ------ · 
NAG is of physiological importance. 
Additionally, when both activators of glutaminase, NH4Cl (1 mM) and glucagon (10-7 M), 
were perfused together there was an increase in the amount of NAG that was greater than with 
either activator alone (Three Factor Analysis of Variance). Since both are known activators of 
glutaminase, our initial results indicate that there may be a possible role to be played by this 
enzyme in the regulation of the urea cycle. The data also showed that the third factor we were 
analysing, glutamine (1 mM), did not alter the NAG content of the liver mitochondria when 
perfused either alone or in the presence of activators (Three Factor Analysis of Variance). We 
assume that, even in the absence of glutamine in the perfusate, there was sufficient intracellular 
glutamine presumably arising from proteolysis. 
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Figure 3.1: Comparison of Citrulline Synthesis and N-Acetylglutamate Levels in 
Mitochondria Prepared from Livers that were Perfused with Activators and 
Substrates of Liver-type Glutaminase. Measurement of the rate of citrulline 
synthesis and N-acetylglutamate levels were performed as described in Material and 
methods section: o·-Medium alone;· •- friiM dlutaiiiine; 0 ~ 1 <FM Glucagon;-e -. ... .. - ... -. - - -
1o-7M Glucagon and 1 mM Glutamine; .1::::. - 1 mM NH4Cl; _. - 1 mM NH4Cl and 1 
mM Glutamine; 0- 10-7M Glucagon and 1 mM NH4Cl; +-10-7M Glucagon and 1 
mM NH4Cl and 1 mM Glutamine. All concentrations reported are the final 
concentrations in the perfusion medium. 
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This initial study was consistent with previous work that showed a positive correlation 
between NAG content and the rate of citrulline synthesis in isolated mitochondria. The data fit a 
rectangular hyperbola that coincides with observations by Stewart and Walser (1980) and Lund 
and Wiggins (1987). The Km for this relationship was 0.9 nmole NAG /mg or 0.9 mM (using 
conventional values of 1 J..Ll matrix volume for 1 mg mitochondrial protein) and the V max was 
found to be 48 nmole/mg protein /minute. This ~ value reported here is consistent with the value 
reported by Stewart and Walser (1980) of0.8 mM within intact mitochondria while our V max is 
within the reported range for intact mitochondria (Meijer et aL 1990). A linear relationship 
between NAG and citrulline synthesis was reported by Morimoto et aL (1990) and Rabier et aL 
(1982). However, this was based on mitochondrial NAG levels up to 1.6 nmole/mg. They had no 
values that extended beyond this point. Thus, their data were fitted to a straight line. In our 
experiment, however, we were able to identify a rectangular hyperbolic relationship as levels of 
mitochondrial NAG exceeded 1.6 nmole/ml. 
Glutaminase Inhibition 
To determine whether NH4Cl and glucagon's effect on NAG content was the result of 
activation of glutaminase or some other unrelated mechanism, we decided to investigate potential 
inhibitors of glutaminase. First we needed to validate a suitable inhibitor of glutaminase. We 
examined two compounds, glutamate-y-hydrazide and 6-diazo-nor-leucine (DON), which had 
been previously reported to be effective inhibitors of glutaminase (Low et aL, 1993; Conti and 
Minelli, 1994; Shapiro et aL, 1979, Matsuno and Hirai, 1989). It should be noted that DON had 
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been previously reported to effectively inhibit kidney-type glutaminase and glutaminase in 
hepatoma cells (Conti and Minelli, 1994; Matsuno and Hirai, 1989). Therefore, our investigation 
ofDON's effect directly on liver-type glutaminase is the first to our knowledge. 
We found that glutamate-y-hydrazide did not inhibit glutaminase activity from freeze-
thawed mitochondria (Figure 3.2), or from intact mitochondria (Figure 3.3), or in isolated 
hepatocytes (Figure 3.4). These results contrast those reported by Low et aL (1993), who 
identified this compound as having a greater than 80% inhibitory effect on glutaminase activity. 
However, we are confident of our results, which were reproducible with batches of glutamate-y-
hydrazide obtained from two different sources. On the other hand, my work with DON showed 
promising results as the compound significantly inhibited glutaminase activity in both freeze-
thawed (Figure 3.5) and intact mitochondria preparations (Figure 3.6). 
We extended our investigation of DON to hepatocytes. As seen in Figure 3.7, flux through 
glutaminase was significantly inhibited by DON in the presence and absence of known activators 
of this enzyme, NH4Cl and glucagon. Although DON does not completely inhibit glutaminase 
activity(~ 40%), We felt that its effect would be sufficient for our investigation of whether a link 
exists between the activation ofliver-type glutaminase and increased NAG levels. We changed 
our experimental protocol from liver perfusions to hepatocyte incubations because of the 
prohibitive cost involved in perfusing our inhibitor at the concentrations required to significantly 
inhibit glutaminase. The amount of inhibitor required for each experiment using hepatocyte 
incubations is only a fraction of that required for perfusion studies. Furthermore, isolated 
hepatocytes have provided comparable results to those in the perfused liver in investigations of 
glucagon and NH4Cl and their effects on NAG levels in liver mitochondria 
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Figure 3.2: The Effect of Glutamate -y-Hydrazide on Glutaminase Activity in Freeze-thawed 
Liver Mitochondria. Activity was measured in rat liver mitochondria that had been 
exposed to three cycles of :freezing ( -70°C) and thawing. This was performed to break 
the mitochondrial membrane. Mitochondrial extracts were then incubated with or 
without 2.5 mM Glutamate -y-Hydrazide (G-y-H) for 10 minutes. Results are means± 
SEM of 3 separate experiments. Results were compared using Student t-test (P < 
0.05). No significant difference was found. 
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Figure 3.3: The Effect of Glutamate -y-Hydrazide on Flux Through Glutaminase in Isolated 
Rat Liver Mitochondria. Flux was measured in freshly isolated, intact rat liver 
mitochondria. Mitochondria were incubated in a final concentration of 2.5 mM 
Glutamate -y-Hydrazide. Results are means ±SEM of3 separate experiments. Results 
were compared using the Student t-test (P < 0.05). No significant difference was 
found. 
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Figure 3.4: The Effect of Glutamate-y-Hydrazide on Flux Through Glutaminase in 
Isolated Rat Liver Hepatocytes. Results shown are the effect of this compound 
on glutaminase in the presence and absence of glucagon. 1 mM NH4Cl was also 
present in both sets of experiments to increase the activation of glutaminase. All 
concentrations reported are the final concentrations within the hepatocyte 
incubation. Results are Means± SEM of three separate experiments. Results were 
analysed using ANOVA followed by Neuman-Keul's post test. No significant 
difference was observed. 
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Figure 3.5: The Effect of 6-Diazo-nor-leucine on Glutaminase Activity in Freeze-thawed 
Liver Mitochondria. Activity was measured in rat liver mitochondria that had been 
exposed to three cycles of freezing (-70°C) and thawing. This was performed to break 
the mitochondrial membrane. Mitochondrial extracts were then incubated with or 
without 5 mM DON (final concentration) for 10 minutes. Results are means± SEM of 
3 separate experiments. Results were compared using Student !-test (P < 0.05): * 
denotes significant differences between gro~;~ps with or without 5 mM DON present. 
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Figure 3.6: The Effect of 6-Diazo-nor-leucine on Flux Through Glutaminase in Isolated Rat 
Liver Mitochondria. Flux was measured in freshly isolated, intact rat liver 
mitochondria. Mitochondria were incubated with a final concentration of5 mM DON. 
Results are means ± SEM of 3 separate experiments. Results were compared using 
Student t-test (P < 0.05): *denotes significant differences between groups with or 
without 5.0 rnM DON present. 
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Figure 3.7: The Effect of 6-Diazo-nor-leucine on Flux Through Glutaminase in Isolated 
Rat Liver Hepatocytes. All concentrations reported are the final concentrations 
within the hepatocyte incubation. Results are Means ± SEM of three separate 
experiments. Results were analysed using Student paired t-test (p< 0.05): *denotes 
significant differences between groups without DON present. 
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(Hensgens et aL, 1980; Zollner, 1981). Therefore, the use ofhepatocyte incubations provided us 
with a cost effective method to investigate the inhibitory effects of DON on these known 
activators. 
Does DON Affect Mitochondrial Integrity? 
Hepatocyte incubations were performed as described in Materials and Methods section. 
After incubation, mitochondria were prepared and analysed for NAG content and the rate of 
citrulline synthesis. It was essential that we determine whether DON treatment ofhepatocytes 
affected mitochondrial integrity. We did this by examining mitochondrial respiration. There was 
no effect of DON on mitochondrial respiration in the presence or absence of ADP (Figure 3.8 A 
vs. 3.8 B). In all cases, respiratory control ratios were greater than 3. Therefore, DON did not 
compromise the assay for citrulline synthesis, which is dependent upon mitochondrial membrane 
integrity. 
Inhibition of Glucagon Stimulated NAG Production by DON 
Mitochondria isolated from hepatocytes which had been incubated with glucagon showed 
significantly higher levels of NAG as expected from our earlier work (0.71 ± 0.04 vs. 0.40 ± 0.07 
nmole/mg mitochondrial protein). In addition, glucagon-treated cells that had been pre-incubated 
with DON were shown to have significantly lower levels of NAG than glucagon treated cells 
incubated without DON (Figure 3.9; p < 0.05). The lowered NAG content due to DON's 
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Figure 3.8: Effect of 6-Diazo-nor-leucine on Mitochondrial Respiration. Mitochondria 
were prepared from isolated hepatocytes as described in Chapter 2. 5 mM 
succinate was used as substrate for oxidative phosphorylation and state 3 
respiration was begun by addition of ADP (0.26 mM; final concentration). The 
mitochondrial concentration was 0.2 mg protein /ml. The concentration of oxygen 
in solution in equilibrium with air at 30oC was taken as 0.24 mM. A- Control 
Mitochondria; B - Mitochondria from DON treated hepatocytes. The figure shows 
an individual experiment but three separate experiments were carried out. 
Respiratory control ratios (- 4) were not significantly different from one another 
(n = 3), Student's paired t-test (p < 0.05). 
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Figure 3.9: N-Acetylglutamate Levels in Mitochondria Isolated from Hepatocytes 
Incubated with/without Glucagon or 6-Diazo-nor-leucine. All incubations 
contained 1 mM Glutamine. Incubation concentrations of Glucagon and DON 
were 10-7M and 5 mM respectively. Cells were pre-incubated with or without DON 
for 20 minutes, then incubated 30 minutes with or without Glucagon. Results are 
means ± S.E.M. of 5 separate experiments. Results were compared using a Student 
t-test: **denotes a significant difference (p < 0.01) compared to the corresponding 
incubations without DON. 
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inhibition of glucagon's effect was also reflected in the rate of citrulline synthesis in those same 
mitochondria. As seen in Figure 3.1 0, the rate of citrulline synthesis was higher in the glucagon 
treated cells than control (34.6 ± 5.2 nmole/mg/minute compared to 16.6 ± 1.3 nmole/mg/minute) 
but was significantly reduced by our inhibitor (34.6 ± 5.2 nmole/mg/minute compared to 24.7 ± 
3.1 nmole/mg/minute ). In our control incubations, DON did not decrease the NAG content and 
rate of citrulline synthesis. 
When the rate of citrulline synthesis in individual mitochondrial preparations is related to 
NAG content (Figure 3.11), the inhibitory effect of DON on glucagon's stimulation becomes 
quite evident. Preparations that were incubated with DON had significantly lower levels ofNAG 
and thus citrulline synthesis. This effect of DON is highly suggestive of a link between activation 
of glutaminase activity by glucagon and subsequent production of NAG. 
Inhibition of NH4Cl-Stimulated NAG Production by DON 
The next step in our investigation was to determine whether the stimulatory effect of 
NH4Cl on mitochondrial NAG levels is influenced by inhibition of glutaminase. Similar methods 
were employed. Hepatocytes were first pre-incubated for 20 minutes, with or without DON. Then 
those cells were incubated with 1 mM glutamine, with or without 1 mM NH4Cl for 30 minutes. 
NH4Cl was found to significantly increase NAG levels in the mitochondria (Figure 3.12; p < 
0.001 ). NAG levels were 180% greater in mitochondria isolated from cells incubated with NH4Cl 
than in control incubations (1.12 ± 0.106 vs. 0.400 ± 0.067 nmole/mg mitochondrial protein). In 
fact, NH4Cl's effect on mitochondrial NAG was greater than the effect mediated by glucagon (57 
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Figure 3.10: The Rate of Citrulline Synthesis in Mitochondria Isolated from Rat 
Liver Hepatocytes Incubated with/without Glucagon and/or 6-Diazo-
nor-leucine. All incubations contained 1 mM Glutamine. Incubation 
concentrations of Glucagon and DON were 10-7M and 5 mM respectively. 
Cells were pre-incubated with or without DON for 20 minutes, then 
incubated 30 minutes with or without Glucagon. Results are the means± 
S.E.M from 5 separate experiments. Results were compared using Student 
t-test (p< 0.05): *denotes a significant difference compared to the 
corresponding incubations without DON. 
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Figure 3.11: Relationship between of Citrulline Synthesis and N-Acetylglutamate 
Levels In Mitochondria Isolated from Incubated Hepatocytes. 
Preparation of mitochondria from hepatocytes, measurement of the rate of 
citrulline synthesis and N-acetylglutamate content as described in Material 
and Methods section: 0- 1 mM glutamine; •- lmM glutamine and 5 mM 
DON; D- Glucagon (10-7 M) and 1 mM glutamine; • -lmM glutamine 
and Glucagon (10-7 M) and 5 mM DON. Incubation concentrations of 
Glucagon and DON were 10-7 M and 5 mM respectively. R = 0.729. (n = 5). 
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Figure 3.12: N-Acetylglutamate Levels in Mitochondria Isolated from Hepatocytes 
Incubated with/without NH4Cl or 6-Diazo-nor-leucine. All hepatocyte 
incubations contained 1 mM Glutamine. Final Concentrations of DON and NH4Cl 
in the incubations were 5 mM and 1 mM respectively. Cells were pre-incubated 
with or without DON for 20 minutes, then incubated 30 minutes with or without 
NH4Cl. Results are means ± S.E.M. of 5 separate experiments. Results were 
compared using a Student t-test: ***denotes a significant difference (p < 0.001) 
compared to the corresponding incubations without DON. 
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% increase). These results suggest that ammonium chloride. is not only a substrate for ureagenesis 
but also seems to be a potent stimulant for the production of the CPS I's essential activator, NAG. 
As NAG levels increase due to stimulation by ammonia, CPS I activity should subsequently 
increase resulting in ammonia removal from the mitochondrial matrix. Mitochondria that had 
been prepared from cells pre-incubated with DON did not show increased NAG levels when 
incubated with NH4Cl (0.328 ± 0.034 nmole/mg mitochondrial protein in DON treated vs. 1.12 ± 
0.106034 nmole/mg mitochondrial protein without DON) (Figure 3.12). 
Measurements of citrulline synthesis in those same mitochondria, however, led to 
unexpected results. Our perfusion study showed a rectangular hyperbolic relationship between 
mitochondrial NAG levels and the rate of citrulline synthesis. This relationship was not observed 
in mitochondria isolated from cells that had been incubated with NH4Cl. The mitochondrial NAG 
content was greatly increased compared to controls but there was no increase in the rate of 
citrulline synthesis (Figure 3.13 and Figure 3.14). 
We further investigated these anomalous results (compared to previous results from 
perfused livers) by measuring the change in ammonia concentration in the hepatocyte incubation 
medium over the 30-minute incubation period. As depicted in Figure 3.15, the levels of ammonia 
became depleted quite rapidly in the incubation medium. This rapid decrease in ammonia from 
the medium over the first five minutes coincided with a significant increase in the rate of citrulline 
synthesis (Figure 3.16). After the initial increase in the rate of citrulline synthesis, there was an 
eventual return to control rates over the course of the incubation (Figure 3 .16). The rates of 
citrulline synthesis in the control experiments also decreased with time. After 30 minutes of 
incubation with ammonia, rate of citrulline synthesis returned to control levels while NAG levels 
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Figure 3.13: The Rate of Citrulline Synthesis in Mitochondria Isolated from Rat Liver 
Bepatocytes Incubated with/without NB4Cl or 6-Diazo-nor-Leucine. All 
hepatocyte incubations contained 1 mM Glutamine. Final Concentrations of DON 
and NH4Cl in the incubations were 5 mM and 1 mM respectively. Cells were pre-
incubated with or without DON for 20 minutes, then incubated 30 minutes with or 
without NH4Cl.Results are the means ± S.E.M from 5 separate experiments. 
Results were compared using Student t-test: *denotes a significant difference (p < 
0.05) compared to the corresponding incubations without DON. 
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Figure 3.14: Relationship between Citrulline Synthesis and N-Acetylglutamate 
Levels in Mitochondria Isolated from Incubated Hepatocytes. Preparation 
of mitochondria from hepatocytes, measurement of the rate of citrulline 
synthesis and N-acetylglutamate content as described in Materials and 
Methods section: 0 - 1 mM glutamine; •- lmM glutamine and 5 mM DON; 
0 - 1 mM NH4Cl and 1 mM glutamine (1 o·7 M); • - 1mM glutamine and 1 
mM NH4Cl and 5 mM DON. Each data point represents an individual 
mitochondrial preparation. 
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Figure 3.15: Removal of Ammonia during Hepatocyte Incubation. Ammonia determination 
was performed on supernatant as described in Materials and Methods: 0 - 1 mM 
glutamine; • - 1mM glutamine and NH4Cl (1 mM). Results are the means± 
S.E.M from 3 separate experiments. 
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Figure 3.16: Citrulline Synthesis in Mitochondria Isolated from Hepatocytes Incubated for 
·Different Time Intervals. Incubations were stopped at each specified time interval 
and preparation of mitochondria from hepatocytes, measurement ofthe rate of 
citrulline synthesis were performed as described in Materials and Methods section. 
Initial incubation concentrations: 0- 1 mM glutamine; •- lmM glutamine and 
NH4Cl (1 mM). Results are the means± S.E.M from 3 separate experiments. 
Results were compared using Student t-test: *denotes a significant difference 
compared to the corresponding incubations without NH4Cl. 
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in the mitochondria were still elevated (Figure 3.10). 
These results could be explained if NAG is sequestered within the mitochondria. It may be 
that NH4Cl initially activates the production of NAG, which coincides with an increase in 
citrulline synthesis, but as NH4Cl becomes depleted in the medium there is no need to further 
activate the urea cycle. Therefore NAG may become sequestered by some unknown mechanism. 
Conceivably, it may be transported out of the matrix to the inter-membrane space. This decreased 
rate of citrulline synthesis cannot be attributed to catabolism of NAG as levels in the 
mitochondria are still elevated after 30 minutes (Figure 3.12). Hence, there may exist some 
unknown mitochondrial down-regulation mechanism which can disrupt the relationship between 
CPS I and NAG. 
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DISCUSSION 
Glucagon's action to increase NAG levels has been well documented but the 
mechanism of this induction has yet to be elucidated (Hensgens et aL, 1980, Rabier et aL, 
1982,Cathelineau et aL, 1980, Cathelineau et aL, 1982). Our results confirmed 
glucagon's effect on NAG levels both in the liver perfusion and in hepatocyte incubations 
(Hensgens et aL, 1980, Rabier et aL, 1982). Furthermore, the positive correlation between 
NAG content and citrulline synthesis seen with our study is in accordance with other 
work and illustrates the dependence of CPS I on NAG as an obligatory activator. Since it 
has been shown previously that glucagon does not increase the activity of NAG 
synthetase (short term), this hormone may exert control by influencing the 
intramitochondrial concentrations of substrates for this enzyme, in particular glutamate 
(Rabier et aL, 1982; Cathelineau et aL, 1982). 
One of the key contributors to intramitochondrial glutamate within the liver is 
glutaminase. This enzyme is activated by glucagon and ammonia. We investigated 
ammonia activation of glutaminase in relation to NAG content. Our results showed that 
ammonia, when perfused through the liver, increased the levels of NAG and subsequent 
citrulline synthesis in mitochondria isolated from rat liver. The effect mediated by 
ammonia suggests that this urea cycle substrate influences its removal, in part, by 
increasing the production of NAG. These results agree with work performed by Zollner 
(1981), who investigated the effects of 10 mM NH4Cl on NAG levels. Although the 
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concentration employed was much greater than in our study (and not physiological), there 
was a significant increase in NAG levels due to ammonia. The use of near physiological 
concentrations (relative to portal vein) of ammonia (1 mM) in our study illustrates that 
this activation is of physiological importance. Zollner (1981) also showed that ammonia 
stimulated a corresponding increase in mitochondrial glutamate levels, which he 
suggested acted as the mediator of ammonia's effect (Zollner, 1981). He also suggested 
that the increase in glutamate levels might be attributed to glutamate synthesis from 
ammonia and a-ketoglutarate by the enzyme glutamate dehydrogenase (Zollner, 1981). 
Since this enzymatic reaction is reversible, he believed that ammonia might mediate its 
effect by stimulating the reverse reaction. On the other hand, we suggest that since 
ammonia is known to be a potent activator of glutaminase activity, increased glutamine 
hydrolysis may account for elevated mitochondrial glutamate levels and subsequent NAG 
levels. 
We examined the relationship between glutaminase and NAG levels through the 
use of the leucine analog 6-diazo-nor-leucine which we found to be a suitable inhibitor of 
glutaminase activity both in mitochondrial (Figure 3.5 and 3.6) and hepatocyte (Figure 
3. 7) preparations. Hepatocyte incubations with this compound showed that glutaminase 
inhibition significantly lowered the effects of glucagon and ammonia on NAG levels. 
This inhibition suggests that NAG levels are mediated by increased provision of 
glutamate as a result of an increase in glutaminase activity. Within glucagon-treated cells, 
the increased levels of NAG led to an increased rate in citrulline synthesis (Figure 3.11 ). 
The lowered NAG levels resulting from pre-incubation of glucagon-treated cells with 
DON had a predictable effect on the rate of citrulline synthesis within those same 
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mitochondria. This, however, was not seen in incubations where ammonia was present. 
The increase in mitochondrial NAG due to ammonia stimulation did not correlate with an 
increase in the rate of citrulline synthesis. As shown in Figure 3.15, ammonia (1 mM) 
becomes exhausted in the incubation medium quite rapidly during the initial five minute 
of incubation. This rapid uptake of ammonia was accompanied by a significant increase 
in the rate of citrulline synthesis (Figure 3.16). With ammonia exhausted in the medium, 
however, the rate of citrulline synthesis decreased until rates similar to control were 
reached (at 30 minutes). These results explain our earlier findings with citrulline 
synthesis where the 30-minute hepatocyte incubation with ammonia had similar rates as 
control although NAG levels were much higher (Figure 3.14). This decreased rate of 
citrulline synthesis cannot be attributed to the catabolism of NAG as levels in the 
mitochondria are still elevated after 30 minutes. Therefore, there may exist some means 
by which mitochondria down-regulate the activation of citrulline synthesis despite 
elevated levels of NAG and optimal assay conditions for citrulline synthesis. The 
mechanism by which the kinetic relationship between NAG levels and citrulline synthesis 
is disrupted remains unknown. 
In our mitochondrial experiments on citrulline synthesis, we assumed that CPS-I 
is the rate-limiting enzyme and that the concentration of NAG, as CPS-I activator, is the 
primary determinant of flux through this enzyme. The literature supports the idea that 
ornithine transcarbamoylase is unlikely to offer any rate limitation (Meijer, 1990). The 
role of the ornithine/citrulline antiporter, however, should be considered with respect to 
the conclusions of this thesis. At present, there exists no evidence that this transporter is 
a target for acute regulation of the urea cycle, however, Morris and Kepka-Lenhart (2002) 
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found that this transporter may be regulated chronically. They found that an increased 
induction of mRNA levels of this transporter occurred when cultured hepatocytes were 
incubated with a cell-permeable cAMP analogue and/or dexamethasone (combination of 
both of these agents was synergistic). This induction occurred over several hours (8-12 
hours) which is much longer than any incubation performed in my study with glucagon 
(30 minutes). These findings by Morris and Kepka-Lenhart (2002) provided no evidence 
that suggested the ornithine/citrulline transporter was a target for acute regulation by 
glucagon (cAMP). Nevertheless, it is not inconceivable that acute regulation of this 
transporter could occur and that it could be important for some of the observations in this 
thesis. In particular, the data in Figure 3.14 suggests that the concentration ofNAG 
cannot be the sole regulator of citrulline synthesis. It is conceivable that an acute effect on 
the transporter could explain these results, however, there is exists no evidence to support 
acute regulation of this transporter. 
The relationship between liver-type glutaminase and NAG was investigated by 
Staddon et aL (1984). Their study involved measuring the change in concentration of 
whole liver metabolites (glutamate, glutamine, and NAG) as a result of glucagon 
stimulation. The idea was that a decrease in glutamine levels with a subsequent increase 
in NAG would suggest the involvement of glutaminase in NAG production. Their results 
suggested that no such relationship exists as NAG levels increased with no evident 
decrease in glutamine levels during the first 10 minutes of exposure to glucagon (Staddon 
et aL, 1984). It is possible that the measurement of whole liver rather than mitochondrial 
metabolite concentration may not provide an accurate assessment of this relationship. 
Also, Staddon et aL (1984) proposed that a lag phase occurred in glucagon's stimulation 
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of glutaminase that corresponded to a decrease in glutamine seen after the initial ten 
minutes. They suggested that glucagon must act through another mechanism to increase 
NAG content because of this lag in glutamine hydrolysis. As seen in our studies, DON's 
inhibition of glutaminase significantly decreased the effect mediated by glucagon. Our 
results provided evidence for the existence of a link between NAG content and the 
stimulation of liver-type glutaminase induced by glucagon and ammonia. 
The existence of this relationship within mitochondria increases our 
understanding of the function of liver-type glutaminase. Glucagon and ammonia increase 
the amount of ammonia and glutamate in the mitochondrial matrix through stimulation of 
glutaminase. Ammonia, in turn, activates further hydrolysis of glutamine by a feedback 
activation mechanism. This type of activation maybe seen as unstable and unsustainable 
but in the context of our findings this regulatory mechanism makes logical sense. As 
ammonia levels increase in the liver (e.g. from the intestine), it activates glutaminase to 
produce glutamate. This glutamate can then be preferentially used by NAG synthetase, 
increasing the intramitochondrial concentration ofNAG. This, in turn, would activate 
carbamoyl-phosphate synthetase I which will mediate the removal of ammonia. 
Therefore, activation of glutaminase will indirectly mediate the removal of its product 
ammonia by its direct provision of glutamate for NAG synthesis. 
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